Adjuvant therapy for gastric cancer: What have we learned since INT0116?

Por Jácome, Alexandre A, Sankarankutty, Ajith K, dos Santos, José Sebastião
Publicado no World J Gastroenterol (2015)

Personalized medicine in gastric cancer: Where are we and where are we going?

Por Jácome, Alexandre A, Coutinho, Anelisa K, Lima, Enaldo M, Andrade, Aline C, dos Santos, José Sebastião
Publicado no World J Gastroenterol (2016)

Effect of adjuvant chemoradiotherapy on overall survival of gastric cancer patients submitted to D2 lymphadenectomy

Por Jácome, Alexandre A. A., Wohnrath, Durval R., Scapulatempo Neto, Cristovam, Fregnani, José Humberto T. G., Quinto, Ana Luiza, Oliveira, Antônio T. T., Vazquez, Vinícius L., Fava, Gilberto, Martinez, Edson Z., Santos, José S.
Publicado em 2012

Development of a new multimedia instrument to measure cancer-specific quality of life in Portuguese-speaking patients with varying literacy skills

Por Paiva, Carlos Eduardo, Siquelli, Felipe Augusto Ferreira, Zaia, Gabriela Rossi, de Andrade, Diocésio Alves Pinto, Borges, Marcos Aristoteles, Jácome, Alexandre A., Giroldo, Gisele Augusta Sousa Nascimento, Santos, Henrique Amorim, Hahn, Elizabeth A., Uemura, Gilberto, Paiva, Bianca Sakamoto Ribeiro
Publicado no Springerplus (2016)

Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal Cancer

Por Johnson, Benny, Loree, Jonathan M., Jacome, Alexandre A., Mendis, Shehara, Syed, Muddassir, Morris II, Van K., Parseghian, Christine M., Dasari, Arvind, Pant, Shubham, Raymond, Victoria M., Vilar, Eduardo, Overman, Michael, Kee, Bryan, Eng, Cathy, Raghav, Kanwal, Kopetz, Scott
Publicado no JCO Precis Oncol (2019)